approval · primary record
DOXYCYCLINE HYCLATE
3 approval events · latest 2025-08-08
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2025-08-08 |
| Approval events | 3 |
| Brand | VIBRAMYCIN |
| Sponsor | PFIZER |
| Route | ORAL |
Approval history
3 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2025-08-08 | FDA | NDA | VIBRAMYCIN | PFIZER | ORAL |
| 2025-04-01 | FDA | NDA | PERIOSTAT | GALDERMA LABS LP | ORAL |
| 2025-03-31 | FDA | NDA | LYMEPAK | CHARTWELL PHARMA | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:30:47.373Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:doxycycline-hyclate
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Doxycycline Hyclate · compound